OUR COMPANY
Harnessing evolution for the next generation of cell therapies
Cell therapy has enormous potential to cure cancer and other diseases, but current methods cannot identify gene enhancements easily, are limited, costly, and have low translatability...
What if there were no boundaries to cell therapy?
Unbiased evolution with CLASH™ unlocks the infinite potential of immune cells to cure solid tumors
Cellinfinity's unbiased evolution platform CLASH™ transforms cell therapy performance by offering:
Speed to discovery
CLASH™ uses machine learning to edit up to 20,000 genes in cells
Precise and replicable
Site-specific edits allow increased precision
Translatability
Select winning genes across multiple assays
We've used CLASH™ to discover universal gene enhancements
>10
HYPERBOOSTS
Novel gain-of-function genes
>30
ENDOMODS
Novel loss-of-function genes
>10
OPTI-CARS
Novel modifications to CAR design
"Additional genetic modifications beyond expressing antigen receptors on T-cells in the setting of adoptive immunotherapy are required to endow immune cells with functional attributes to overcome the solid tumour microenvironment. CLASH has identified a series of gene enhancements that substantially enhance the power of immune cells to kill cancers. We are rapidly advancing these next-generation engineered cells towards the clinic.”
Margo Roberts, PhD
Former CSO of Kite Pharma and Chief Scientific Advisor at Cellinfinity Bio
Introducing Supercharged Cell Therapy™
Powered by multi-gene enhancements discovered with CLASH™
HYPERBOOOST
OPTI-CAR
Increased solid tumor killing
ENDOMOD
Supercharged CAR-T and CAR-NK cells™ are programmed with several gene enhancements that increase potency, persistence, penetration and memory, allowing enhanced efficacy against solid tumors
